Literature DB >> 20178704

Verrucous carcinoma of the foot affecting the bone: utility of the computed tomography scanner.

J García-Gavín1, D González-Vilas, L Rodríguez-Pazos, D Sánchez-Aguilar, J Toribio.   

Abstract

Verrucous Carcinoma (VC) of the foot often affects deep structures such as tendons, muscles or bone. The complete removal of the tumor is essential to avoid recurrences. Radiological studies should be performed before surgical planning in order to determine the extent of the tumor. A 54-year-old man presented with a VC of the foot. Magnetic resonance imaging (MRI) demonstrated a soft-tissue mass affecting the plantar aponeurosis and the sole muscles, without evidence of bone invasion. Computed tomography (CT) showed a lytic area with cortical disruption in the fourth metatarsal neck. A transmetatarsal amputation was performed. Histopathological examination confirmed the bone invasion. MRI is considered the imaging technique of choice in studying VC of the foot. Computed tomography is superior to MRI in determining minimum changes in the cortical bone related to tumor invasion. We conclude that when MRI images are not conclusive, CT scan is a good alternative to determine incipient bone invasion.

Entities:  

Mesh:

Year:  2010        PMID: 20178704

Source DB:  PubMed          Journal:  Dermatol Online J        ISSN: 1087-2108


  3 in total

1.  Inverted verrucous carcinoma of the buttock mimicking abscess and gossypiboma: MR and pathologic correlation.

Authors:  Bing Hu; Tetyana Gorbachova; Paul Belser; Shuchi K Rodgers; Robert Schiowitz
Journal:  Skeletal Radiol       Date:  2015-05-10       Impact factor: 2.199

2.  Verrucous carcinoma of the foot with bone invasion: a case report.

Authors:  C Pempinello; A Bova; R Pempinello; R Luise; G Iannaci
Journal:  Case Rep Oncol Med       Date:  2013-04-09

3.  Carcinoma Cuniculatum: Usefulness of Radiological Assessment.

Authors:  Nicola di Meo; Giuseppe Stinco; Katiuscia Nan; Ferruccio Degrassi; Maria Assunta Cova; Giusto Trevisan
Journal:  Indian J Dermatol       Date:  2016 Jan-Feb       Impact factor: 1.494

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.